Clinical Trial Update: Safety Study of Bone Marrow Derived Cells to Treat Damaged Heart Muscle [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 safety study evaluating bone marrow–derived cells for treating damaged heart muscle in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Bone marrow derived cells

Snippet

Sponsor: Neuronyx | Conditions: Myocardial Infarction | Phase 1 | Status: COMPLETED